127 related articles for article (PubMed ID: 9565044)
1. Reactivation of inflammatory lesions in ocular histoplasmosis.
Callanan D; Fish GE; Anand R
Arch Ophthalmol; 1998 Apr; 116(4):470-4. PubMed ID: 9565044
[TBL] [Abstract][Full Text] [Related]
2. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome.
Thomas MA; Kaplan HJ
Am J Ophthalmol; 1991 Jan; 111(1):1-7. PubMed ID: 1985467
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study.
Rosenfeld PJ; Saperstein DA; Bressler NM; Reaves TA; Sickenberg M; Rosa RH; Sternberg P; Aaberg TM; Aaberg TM;
Ophthalmology; 2004 Sep; 111(9):1725-33. PubMed ID: 15350329
[TBL] [Abstract][Full Text] [Related]
4. massive peripapillary subretinal neovascularization: an indication for submacular surgery.
Kertes PJ
Retina; 2004 Apr; 24(2):219-25. PubMed ID: 15097881
[TBL] [Abstract][Full Text] [Related]
5. Correlation between scanning laser ophthalmoscope microperimetry and anatomic abnormalities in patients with subfoveal neovascularization.
Tezel TH; Del Priore LV; Flowers BE; Grosof DH; Benenson IL; Zamora RL; Kaplan HJ
Ophthalmology; 1996 Nov; 103(11):1829-36. PubMed ID: 8942878
[TBL] [Abstract][Full Text] [Related]
6. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
[TBL] [Abstract][Full Text] [Related]
7. Bimanual technique of subfoveal neovascular membrane removal in presumed ocular histoplasmosis.
Peyman GA; Lee KJ; Nelson NC; Ma PE
Int Ophthalmol; 1993 Feb; 17(1):43-6. PubMed ID: 8314661
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of a long-standing subfoveal neovascular membrane secondary to ocular histoplasmosis.
Wind BE; Sobol WM
Ophthalmic Surg; 1993 Jan; 24(1):36-9. PubMed ID: 7680442
[TBL] [Abstract][Full Text] [Related]
9. Surgical removal of subretinal neovascular membranes.
Maas S; Deutman AF; Bandhoe F; Aandekerk AL
Eur J Ophthalmol; 1995; 5(1):48-55. PubMed ID: 7795401
[TBL] [Abstract][Full Text] [Related]
10. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis.
Berger AS; Conway M; Del Priore LV; Walker RS; Pollack JS; Kaplan HJ
Arch Ophthalmol; 1997 Aug; 115(8):991-6. PubMed ID: 9258220
[TBL] [Abstract][Full Text] [Related]
11. Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
Atebara NH; Thomas MA; Holekamp NM; Mandell BA; Del Priore LV
Ophthalmology; 1998 Sep; 105(9):1598-605. PubMed ID: 9754163
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndrome.
Ehrlich R; Ciulla TA; Maturi R; Kheradiya NS; Hrisomalos N; Shulman S; Guess MG; Coyle E; Harris A
Retina; 2009; 29(10):1418-23. PubMed ID: 19898179
[TBL] [Abstract][Full Text] [Related]
13. Presumed ocular histoplasmosis syndrome.
Prasad AG; Van Gelder RN
Curr Opin Ophthalmol; 2005 Dec; 16(6):364-8. PubMed ID: 16264347
[TBL] [Abstract][Full Text] [Related]
14. The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1995 Feb; 113(2):190-4. PubMed ID: 7532395
[TBL] [Abstract][Full Text] [Related]
15. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes.
Sickenberg M; Schmidt-Erfurth U; Miller JW; Pournaras CJ; Zografos L; Piguet B; Donati G; Laqua H; Barbazetto I; Gragoudas ES; Lane AM; Birngruber R; van den Bergh H; Strong HA; Manjuris U; Gray T; Fsadni M; Bressler NM
Arch Ophthalmol; 2000 Mar; 118(3):327-36. PubMed ID: 10721954
[TBL] [Abstract][Full Text] [Related]
16. Presumed ocular histoplasmosis syndrome in India.
Sinha R; Raju S; Garg SP; Venkatesh P; Talwar D
Ocul Immunol Inflamm; 2007; 15(4):315-7. PubMed ID: 17763129
[TBL] [Abstract][Full Text] [Related]
17. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9.
Hawkins BS; Bressler NM; Bressler SB; Davidorf FH; Hoskins JC; Marsh MJ; Miskala PH; Redford M; Sternberg P; Thomas MA; Toth CA;
Arch Ophthalmol; 2004 Nov; 122(11):1597-611. PubMed ID: 15534121
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of surgical removal of extensive peripapillary choroidal neovascularization in presumed ocular histoplasmosis syndrome.
Almony A; Thomas MA; Atebara NH; Holekamp NM; Del Priore LV
Ophthalmology; 2008 Mar; 115(3):540-545.e5. PubMed ID: 17988741
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization.
Martidis A; Miller DG; Ciulla TA; Danis RP; Moorthy RS
J Ocul Pharmacol Ther; 1999 Oct; 15(5):425-8. PubMed ID: 10530703
[TBL] [Abstract][Full Text] [Related]
20. Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis.
Olk RJ; Burgess DB; McCormick PA
Ophthalmology; 1984 Dec; 91(12):1592-602. PubMed ID: 6084225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
